What you need to know
- Android 16 is rolling out for two of Asus’ flagship phones, the ROG Phone 9 and Zenfone 12 Ultra.
- The update, which is around 1GB in size, includes various bug fixes and feature improvements.
- The update is rolling out…



The Australian market is experiencing turbulence, with the ASX 200 futures indicating a significant drop following the recent end of the U.S. government shutdown and ongoing economic uncertainties. Despite this volatility, penny stocks continue to capture investor interest due to their affordability and potential for growth. While often associated with smaller or newer companies, these stocks can offer intriguing opportunities when backed by strong financials and strategic positioning. In this article, we’ll explore three noteworthy penny stocks on the ASX that stand out for their potential resilience and growth prospects amidst current market conditions.
|
Name |
Share Price |
Market Cap |
Financial Health Rating |
|
Alfabs Australia (ASX:AAL) |
A$0.45 |
A$128.96M |
★★★★★☆ |
|
Dusk Group (ASX:DSK) |
A$0.84 |
A$52.31M |
★★★★★★ |
|
IVE Group (ASX:IGL) |
A$3.01 |
A$462.61M |
★★★★★☆ |
|
MotorCycle Holdings (ASX:MTO) |
A$3.73 |
A$275.3M |
★★★★★★ |
|
West African Resources (ASX:WAF) |
A$3.04 |
A$3.47B |
★★★★★★ |
|
LaserBond (ASX:LBL) |
A$0.50 |
A$59.04M |
★★★★★★ |
|
Bravura Solutions (ASX:BVS) |
A$2.31 |
A$1.04B |
★★★★★★ |
|
Praemium (ASX:PPS) |
A$0.81 |
A$387.52M |
★★★★★★ |
|
Service Stream (ASX:SSM) |
A$2.25 |
A$1.38B |
★★★★★★ |
|
GWA Group (ASX:GWA) |
A$2.38 |
A$624.51M |
★★★★★☆ |
Click here to see the full list of 414 stocks from our ASX Penny Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Immutep Limited is a biotechnology company focused on developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia, with a market cap of A$404.78 million.
Operations: Immutep generates revenue primarily from its immunotherapy segment, which accounts for A$5.03 million.
Market Cap: A$404.78M
Immutep Limited, a biotechnology company with a market cap of A$404.78 million, is currently pre-revenue and unprofitable, reporting A$5.03 million in revenue from its immunotherapy segment. Despite this, the company has made significant strides in clinical trials for its novel LAG-3 related immunotherapies like eftilagimod alfa (efti), which has shown promising results in treating various cancers including non-small cell lung cancer and soft tissue sarcoma. Recent positive trial data and FDA Fast Track designations highlight potential future growth avenues. Immutep’s financial stability is bolstered by sufficient cash reserves exceeding its liabilities.

New Zealand’s Daryl Mitchell bats during the first one-day international cricket match between New Zealand and West Indies at Hagley Oval in Christchurch on November 16, 2025.
| Photo…

Renowned computer scientist Yoshua Bengio has made history by becoming the first living researcher to surpass one million citations on Google Scholar, a milestone almost unheard of in modern academia. The achievement reflects not only…

FRISCO, Texas – A Frisco woman has been sentenced to eight years in federal prison for making false statements related to international terrorism, Acting U.S. Attorney Jay R. Combs announced.
Kahkashan Haider Khan, 54, a U.S….

Meditation app Headspace is bringing back one of its biggest annual deals this Black Friday. Through December 4, you’ll be able to get 50 percent off the regular annual subscription price, bringing a full year of guided meditations, sleep…

Fake AI-generated Avengers: Doomsday leaks featuring Downey Jr. and Maguire flood social media ahead of 2026 release
As anticipation builds for Avengers:…

CINCINNATI, Ohio. – The Marquette University women’s volleyball team (17-9, 11-5 BIG EAST) snapped the 13-match win streak of Xavier (25-3, 14-2 BIG EAST) with a four-set victory Sunday afternoon at the Cintas Center.
Natalie Ring led…

Italian tennis star Jannik Sinner defeated Spain’s Carlos Alcaraz 7-6 (7-4), 7-5 at the 2025 ATP Finals championship match in Turin, Italy, on Sunday (16 November).
Sinner has appeared in the last three ATP Finals championships matches,…